These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 202141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects.
    Attman PO, Aurell M, Johnsson G.
    Eur J Clin Pharmacol; 1975 Apr 04; 8(3-4):201-4. PubMed ID: 1233219
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG, Johnsson G, Jordö L, Lungborg P, Persson BA, Rönn O.
    J Cardiovasc Pharmacol; 1980 Apr 04; 2(6):715-23. PubMed ID: 6160322
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS, Comerford MB, Sowton E.
    J Int Med Res; 1976 Apr 04; 4(1):15-22. PubMed ID: 799974
    [Abstract] [Full Text] [Related]

  • 11. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM, Singh BN, Ambler PK, Dorrington R.
    Clin Exp Pharmacol Physiol; 1976 Apr 04; 3(5):473-82. PubMed ID: 975632
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of metoprolol and propranolol in modification of haemodynamic and renin-aldosterone responses to tilting in humans.
    Viol GW, Smith EK, Fitzgerald JD.
    Clin Sci Mol Med Suppl; 1976 Dec 04; 3():533s-535s. PubMed ID: 1071676
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE, Cragg DJ, Bacon RJ.
    Br J Clin Pharmacol; 1984 Sep 04; 18(3):343-7. PubMed ID: 6148959
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension.
    von Bahr C, Collste P, Frisk-Holmberg M, Haglund K, Jorfelt L, Orme M, Ostman J, Sjoqvist F.
    Clin Pharmacol Ther; 1976 Aug 04; 20(2):130-7. PubMed ID: 7373
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R, Koulu M, Allonen H.
    Int J Clin Pharmacol Biopharm; 1979 Jun 04; 17(6):240-43. PubMed ID: 38214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.